10 Worst Performing Medtech Firms Of Early 2016
From tougher price bargaining from customers to uncertainty over a next-generation LVAD, some medical device companies have stories that are proving to be a tough sell to investors this year.
In fact, 56 out of 91 major medical device companies analyzed by Qmed saw their stock values decline during the first three months of the year. (Download Qmed’s full spreadsheet of the 91 stocks.)
In fact, 56 out of 91 major medical device companies analyzed by Qmed saw their stock values decline during the first three months of the year. (Download Qmed’s full spreadsheet of the 91 stocks.)